Virtue Asset Management’s Amgen AMGN Stock Holding History

Virtue Asset Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.16M	Buy	3,193 +833	+35%	+$285K	0.81%	42
2026 Q1	$830K	Buy	+2,360	New	+$841K	0.66%	48

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Virtue Asset Management's AMGN Position: Q2 2026 in Review

Virtue Asset Management increased its Amgen (AMGN) stake by 35% in Q2 2026, buying an estimated $285K and bringing the position to 3,193 shares worth $1.16M. The position accounts for 0.81% of the portfolio, ranked #42.

Virtue Asset Management first reported a position in AMGN in Q1 2026 and has held it in 2 quarters since. 3,145 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Virtue Asset Management held 3,193 shares of Amgen worth $1.16M as of Q2 2026.
Virtue Asset Management bought 833 Amgen shares in Q2 2026, an estimated $285K.
Amgen made up 0.81% of Virtue Asset Management's portfolio in Q2 2026, its #42 holding.
Virtue Asset Management first reported a position in Amgen in Q1 2026 and has held it in 2 quarters since.
3,145 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Virtue Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.